Target intelligence / Profile preview

Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase (CobT)

Target
CobT
Molecular classification
Enzyme, Glycosyltransferase, Pentosyltransferase
01

Overview

Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase (EC 2.4.2.21), also known as CobT, is an enzyme that catalyzes the phosphoribosyltransfer reaction essential for the biosynthesis of cobalamin (vitamin B12) in bacteria. It converts beta-nicotinate D-ribonucleotide and 5,6-dimethylbenzimidazole into alpha-ribazole-5'-phosphate, a key intermediate for assembling the nucleotide loop of cobalamin. CobT is a glycosyltransferase of the pentosyltransferase family and plays a central role in the anaerobic pathway of vitamin B12 production. Structurally, CobT is a dimer with each subunit featuring a Rossmann fold and a three-helix bundle domain. The enzyme’s active site forms a hydrophobic pocket accommodating the substrate 5,6-dimethylbenzimidazole, and it undergoes a disorder-to-order transition upon substrate binding. It is distinct in structure from other phosphoribosyltransferases, and its function is crucial for bacterial metabolism but not directly linked to human enzymes or diseases[1][2][4][7][10].

Other names
Nicotinate mononucleotide-dimethylbenzimidazole phosphoribosyltransferaseNicotinate ribonucleotide:benzimidazole (adenine) phosphoribosyltransferaseNicotinate mononucleotide (NaMN):5,6-dimethylbenzimidazole phosphoribosyltransferaseCobT
02

Biological functions

Catalyzes the synthesis of alpha-ribazole-5'-phosphate from nicotinate mononucleotide and 5,6-dimethylbenzimidazoleParticipates in the anaerobic cobalamin (vitamin B12) biosynthesis pathway in bacteriaInvolved in nucleotide loop assembly and lower ligand synthesis of cobalamin
03

Disease associations

Not directly implicated in human diseases (bacterial enzyme)Indirectly relevant by virtue of role in bacterial vitamin B12 synthesis, potentially a target in antibacterial development

Beyond the preview

Go deeper on Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase (CobT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase (CobT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call